🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Takahiro Nishio

Kyoto University

ORCID: 0000-0002-9676-7235

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Immunotherapy-based targeting of MSLN + activated portal fibroblasts is a strategy for treatment of cholestatic liver fibrosis”.

Immunotherapy-based targeting of MSLN + activated portal fibroblasts is a strategy for treatment of cholestatic liver fibrosis

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2101270118

N/A

0DataRank · unranked

29 citations

Yukinori Koyama, Xiao Liu, Sara Brin Rosenthal, Gen Yamamoto, Hiroaki Fuji +12 more

Nondegradable Collagen Increases Liver Fibrosis but Not Hepatocellular Carcinoma in Mice

American Journal Of Pathology(2021)10.1016/j.ajpath.2021.05.019

N/A

0DataRank · unranked

25 citations

Cuili Zhang, Shuang Liang, Xiao Liu, Takahiro Nishio, Sara Brin Rosenthal +9 more

The role of Mesothelin signaling in Portal Fibroblasts in the pathogenesis of cholestatic liver fibrosis

Frontiers in Molecular Biosciences(2021)10.3389/fmolb.2021.790032

N/A

0DataRank · unranked

17 citations

Grant G. Miller, Takahiro Nishio, Yukinori Koyama, Kevin Lam, Vivian Zhang +4 more

The Role of Mesothelin in Activation of Portal Fibroblasts in Cholestatic Liver Injury

Biology(2022)10.3390/biology11111589

N/A

0DataRank · unranked

8 citations

Yukinori Koyama, Hiroaki Fuji, Kei Ishizuka, Keiko Iwaisako, Kojiro Taura +4 more